SG11201609490QA - Polymer-flavonoid conjugate and uses thereof - Google Patents
Polymer-flavonoid conjugate and uses thereofInfo
- Publication number
- SG11201609490QA SG11201609490QA SG11201609490QA SG11201609490QA SG11201609490QA SG 11201609490Q A SG11201609490Q A SG 11201609490QA SG 11201609490Q A SG11201609490Q A SG 11201609490QA SG 11201609490Q A SG11201609490Q A SG 11201609490QA SG 11201609490Q A SG11201609490Q A SG 11201609490QA
- Authority
- SG
- Singapore
- Prior art keywords
- polymer
- flavonoid conjugate
- flavonoid
- conjugate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG11201609490QA SG11201609490QA (en) | 2014-05-15 | 2015-05-15 | Polymer-flavonoid conjugate and uses thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201402361X | 2014-05-15 | ||
PCT/SG2015/050117 WO2015174934A1 (fr) | 2014-05-15 | 2015-05-15 | Conjugué polymere-flavonoïde et utilisations associées |
SG11201609490QA SG11201609490QA (en) | 2014-05-15 | 2015-05-15 | Polymer-flavonoid conjugate and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201609490QA true SG11201609490QA (en) | 2016-12-29 |
Family
ID=54480328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201609490QA SG11201609490QA (en) | 2014-05-15 | 2015-05-15 | Polymer-flavonoid conjugate and uses thereof |
Country Status (6)
Country | Link |
---|---|
US (1) | US10406175B2 (fr) |
EP (1) | EP3142705B1 (fr) |
JP (1) | JP6661546B2 (fr) |
CN (1) | CN106456797A (fr) |
SG (1) | SG11201609490QA (fr) |
WO (1) | WO2015174934A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3041830B1 (fr) * | 2013-09-03 | 2023-10-25 | Agency For Science, Technology And Research | Conjugués polymère-flavonoïde et hydrogels pour applications biomédicales |
CN105381470B (zh) * | 2015-11-27 | 2018-11-02 | 广东医科大学 | 一种改性染料木素及其应用 |
EP3578573A4 (fr) * | 2017-02-02 | 2020-11-18 | Amtixbio Co., Ltd. | Hydrogel utilisant en tant que substrat un derivé d'acide hyaluronique modifié par un groupe gallol, et utilisation associée |
KR20190050416A (ko) | 2017-11-03 | 2019-05-13 | 전북대학교산학협력단 | miRNA-140-5p가 함유된 젤란검 하이드로겔 조성물과 이를 이용한 연골손상 치료용 조성물 |
US20210017348A1 (en) * | 2018-04-02 | 2021-01-21 | Optipharm Co., Ltd | Alginate microcapsules for cell encapsulation and, manufacturing method therefor |
KR102076769B1 (ko) * | 2018-04-24 | 2020-02-12 | 바이오스트림테크놀러지스(주) | 히알루론산-플라보노이드 컨쥬게이트, 이를 포함하는 나노입자 및 이의 제조방법 |
KR102181502B1 (ko) * | 2018-08-17 | 2020-11-23 | 한양대학교 산학협력단 | 에피갈로카테킨 갈레이트가 코팅된 고분자 복합체의 제조방법 및 상기 방법에 따라 제조된 고분자 복합체 |
KR102156602B1 (ko) | 2019-10-17 | 2020-09-16 | 전북대학교산학협력단 | miRNA-140-5p가 함유된 젤란검 하이드로겔 조성물과 이를 이용한 연골손상 치료용 조성물 |
KR102440783B1 (ko) * | 2020-06-15 | 2022-09-06 | 한양대학교 산학협력단 | 폴리페놀 기반의 미네랄 입자가 코팅된 유-무기 복합체의 제조방법 및 이에 따라 제조된 유-무기 복합체 |
CN115702937A (zh) * | 2021-08-04 | 2023-02-17 | 四川大学 | 改性多酚载体材料、靶向纳米递送系统及制备方法和用途 |
CA3227319A1 (fr) * | 2021-09-16 | 2023-03-23 | Coval Biopharma (Shanghai) Co., Ltd. | Systeme d'administration de medicament pour administrer localement des agents therapeutiques et utilisations de celui-ci |
CN114259602B (zh) * | 2021-12-29 | 2022-09-30 | 江苏江山聚源生物技术有限公司 | 注射用重组胶原蛋白水凝胶及其制备方法 |
CN114366710B (zh) * | 2022-01-20 | 2023-11-17 | 苏州大学附属第一医院 | 可注射型牛蒡微载体在治疗晚期骨性关节炎中的用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8713662D0 (en) | 1987-06-11 | 1987-07-15 | Skandigen Ab | Hyaluronic acid derivatives |
FR2699819B1 (fr) * | 1992-12-28 | 1995-02-24 | Dolisos Lab | Utilisation de prodelphinidines pour l'obtention de médicaments destinés au traitement de l'arthrose. |
JPH07238079A (ja) * | 1994-02-25 | 1995-09-12 | Lotte Co Ltd | カテキン化合物、その製造方法およびこれを用いる消臭剤 |
WO2000074662A2 (fr) * | 1999-06-07 | 2000-12-14 | University Of Sheffield | Traitement de l'arthrite |
US6428817B1 (en) | 1999-07-06 | 2002-08-06 | Peter Donald Collin | Companion animal therapeutic treat |
AU2003236076A1 (en) | 2002-03-22 | 2003-10-08 | Beijing Jiankai Technology Co., Ltd. | Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them |
WO2006124000A1 (fr) * | 2005-05-20 | 2006-11-23 | Agency For Science, Technology And Research | Preparations de flavonoides conjugues a des aldehydes |
US7858080B2 (en) | 2005-05-20 | 2010-12-28 | Agency For Science, Technology And Research | Aldehyde conjugated flavonoid preparations |
WO2011019323A1 (fr) * | 2009-08-11 | 2011-02-17 | Agency For Science Technology And Research | Formulations particulaires d'acide hyaluronique pour l'apport cellulaire d'agents bioactifs |
CN103635802B (zh) | 2011-04-13 | 2015-10-21 | 阿科尼生物系统公司 | 基于微阵列的样检系统 |
WO2013063086A1 (fr) * | 2011-10-24 | 2013-05-02 | Intellect Neurosciences, Inc. | Compositions et méthodes de traitement de protéinopathies |
EP3041830B1 (fr) | 2013-09-03 | 2023-10-25 | Agency For Science, Technology And Research | Conjugués polymère-flavonoïde et hydrogels pour applications biomédicales |
GB2518405A (en) * | 2013-09-20 | 2015-03-25 | Zeiss Carl Meditec Ag | Composition comprising at least one viscoelastic polymer |
-
2015
- 2015-05-15 WO PCT/SG2015/050117 patent/WO2015174934A1/fr active Application Filing
- 2015-05-15 SG SG11201609490QA patent/SG11201609490QA/en unknown
- 2015-05-15 CN CN201580029666.2A patent/CN106456797A/zh active Pending
- 2015-05-15 EP EP15792453.1A patent/EP3142705B1/fr active Active
- 2015-05-15 JP JP2016567350A patent/JP6661546B2/ja not_active Expired - Fee Related
- 2015-05-15 US US15/308,725 patent/US10406175B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2015174934A1 (fr) | 2015-11-19 |
US20170216446A1 (en) | 2017-08-03 |
JP2017515834A (ja) | 2017-06-15 |
US10406175B2 (en) | 2019-09-10 |
WO2015174934A9 (fr) | 2016-06-09 |
EP3142705A1 (fr) | 2017-03-22 |
EP3142705B1 (fr) | 2020-08-19 |
JP6661546B2 (ja) | 2020-03-11 |
EP3142705A4 (fr) | 2017-11-22 |
CN106456797A (zh) | 2017-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL258248A (en) | Attraction Oligonucleotide Conjugates and Their Uses | |
HK1231471A1 (zh) | -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途 | |
IL252216A0 (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
SG11201609490QA (en) | Polymer-flavonoid conjugate and uses thereof | |
PL3152226T3 (pl) | Modyfikowane cyklopentapeptydy i ich zastosowania | |
GB201401617D0 (en) | Novel combination and use | |
SG11201608943VA (en) | Substituted 4-phenylpiperidines, their preparaiton and use | |
HK1243950A1 (zh) | 新型組合物和用途 | |
SG11201704473WA (en) | New methods and uses | |
HK1243077A1 (zh) | 呱啶基吡唑並嘧啶酮及其用途 | |
IL258759A (en) | Anti-cd3-folate conjugates and their uses | |
HK1247122A1 (zh) | 組合及其用途 | |
IL254241A0 (en) | Etv2 and its uses | |
GB201408091D0 (en) | Methods and uses | |
SG11201700191PA (en) | Microbiocides and uses thereof | |
PL3229772T3 (pl) | 6-arylo-9-glikozylopuryny i ich zastosowanie | |
GB201416086D0 (en) | Methods and uses | |
GB201416073D0 (en) | Methods and uses | |
GB201404728D0 (en) | Disc-over incorporating disc-heads and disc-earning | |
TWM489086U (en) | Shape fitting bookmark and shape fitting bookmark set | |
GB201404438D0 (en) | Polyamine compounds and uses thereof |